TRLS-01. INTRAVENTRICULAR B7-H3 CAR T CELLS FOR DIFFUSE INTRINSIC PONTINE GLIOMA: SAFETY AND EFFICACY REPORT FROM THE COMPLETED PHASE 1 TRIAL BRAINCHILD-03
Nicholas A. Vitanza(Seattle Children's Hospital), Michael C. Jensen(Seattle Children's Hospital), Jason S. Hauptman(Seattle Children's Hospital), Julie R. Park(Seattle Children's Hospital), Joshua A. Gustafson(Seattle Children's Hospital), Erin Crotty(Seattle Children's Hospital), Rebecca Ronsley(Seattle Children's Hospital), Sarah Leary(Seattle Children's Hospital), Jason Wendler(Pacific Northwest National Laboratory), Rebecca Gardner(Seattle Children's Hospital), Kristy Seidel(Fred Hutch Cancer Center), Colleen Annesley(Unknown), Wenjuan Huang(Xuzhou Medical College), Michlle Choe(Seattle Children's Hospital), On Ho, Juliane Gust(University of Washington), Alison Thomsen(Seattle Children's Hospital), Sowmya Pattabhi
Cited by 3
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k